FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Flora Haaijer-Ruskamp

Research Profile

Geographic Areas

Concepts & Ideas

Activities & Behaviors

Disorders

Occupations

Family Practice

Chemicals & Drugs

Co-author Network

Publications

TOP 3
K C Reber; Sabine M J M Straus; J E Wieringa; Pieter A de Graeff; Flora M Haaijer-Ruskamp; S Piening; J M Raine; Peter G M Mol
When direct health-care professional communications have an impact on inappropriate and unsafe use of medicines.
Grigory Sidorenkov; Voorham Jaco; Dick de Zeeuw; Flora M Haaijer-Ruskamp; Petra Denig
Treatment quality indicators predict short-term outcomes in patients with diabetes: a prospective cohort study using the GIANTT database.
Grigory Sidorenkov; Jaco Voorham; Dick de Zeeuw; Flora M Haaijer-Ruskamp; Petra Denig
Association between performance measures and glycemic control among patients with diabetes in a community-wide primary care cohort.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Flora Haaijer-Ruskamp (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: K C Reber; Sabine M J M Straus; J E Wieringa; Pieter A de Graeff; Flora M Haaijer-Ruskamp; S Piening; J M Raine; Peter G M Mol
When direct health-care professional communications have an impact on inappropriate and unsafe use of medicines.
Clinical pharmacology and therapeutics 2013;93(4):360-5.
2013: Grigory Sidorenkov; Voorham Jaco; Dick de Zeeuw; Flora M Haaijer-Ruskamp; Petra Denig
Treatment quality indicators predict short-term outcomes in patients with diabetes: a prospective cohort study using the GIANTT database.
BMJ quality & safety 2013;22(4):339-47.
2013: Grigory Sidorenkov; Jaco Voorham; Dick de Zeeuw; Flora M Haaijer-Ruskamp; Petra Denig
Association between performance measures and glycemic control among patients with diabetes in a community-wide primary care cohort.
Medical care 2013;51(2):172-9.
2012: Sigrid Piening; Sabine M J M Straus; Pieter A de Graeff; Flora M Haaijer-Ruskamp; Peter G M Mol
Healthcare professionals' self-reported experiences and preferences related to direct healthcare professional communications: a survey conducted in the Netherlands.
Drug safety : an international journal of medical toxicology and drug experience 2012;35(11):1061-72.
2012: Liana Martirosyan; Flora M Haaijer-Ruskamp; Jozé Braspenning; Petra Denig
Development of a minimal set of prescribing quality indicators for diabetes management on a general practice level.
Pharmacoepidemiology and drug safety 2012;21(10):1053-9.
2012: Sigrid Piening; Sabine M J M Straus; Menno E van der Elst; Pieter A de Graeff; Jonie T N de Vries; Flora M Haaijer-Ruskamp; Peter G M Mol
Impact of safety-related regulatory action on clinical practice: a systematic review.
Drug safety : an international journal of medical toxicology and drug experience 2012;35(5):373-85.
2012: S Piening; K C Reber; Sabine M J M Straus; J E Wieringa; Pieter A de Graeff; Flora M Haaijer-Ruskamp; Peter G M Mol
Impact of safety-related regulatory action on drug use in ambulatory care in the Netherlands.
Clinical pharmacology and therapeutics 2012;91(5):838-45.
2012: Petra Denig; Mathijs Dun; Flora M Haaijer-Ruskamp; Jan Schuling; Voorham Jaco
The effect of a patient-oriented treatment decision aid for risk factor management in patients with diabetes (PORTDA-diab): study protocol for a randomised controlled trial.
Trials 2012;13():219.
2012: Liana Martirosyan; Petra Denig; Flora M Haaijer-Ruskamp; Joekie Markhorst; Jozé Braspenning
A pilot qualitative study to explore stakeholder opinions regarding prescribing quality indicators.
BMC health services research 2012;12():191.
2012: Jan Schuling; LJ Veehof; Henkjan Gebben; Flora M Haaijer-Ruskamp
Deprescribing medication in very elderly patients with multimorbidity: the view of Dutch GPs. A qualitative study.
BMC family practice 2012;13():56.
2012: Jaco Voorham; Bruce H R Wolffenbuttel; Dick De Zeeuw; Flora M Haaijer-Ruskamp; Ronald P Stolk; Petra Denig
Differential effects of comorbidity on antihypertensive and glucose-regulating treatment in diabetes mellitus--a cohort study.
PloS one 2012;7(6):e38707.
2012: R H De Smedt; Klaas H Groenier; Flora M Haaijer-Ruskamp; Tiny Jaarsma; A V Ranchor; Klaas van der Meer; Petra Denig
Coping with adverse drug events in patients with heart failure: Exploring the role of medication beliefs and perceptions.
Psychology & health 2012;27(5):570-87.
2011: Liana Hakobyan; Dick De Zeeuw; Daniela Dobre; Flora M Haaijer-Ruskamp; Petra Denig
Comparing adverse event rates of oral blood glucose-lowering drugs reported by patients and healthcare providers: a post-hoc analysis of observational studies published between 1999 and 2011.
Drug safety : an international journal of medical toxicology and drug experience 2011;34(12):1191-202.
2011: Ruth H E De Smedt; Petra Denig; Flora M Haaijer-Ruskamp; Klaas van der Meer; Tiny Jaarsma
Self-reported adverse drug events and the role of illness perception and medication beliefs in ambulatory heart failure patients: A cross-sectional survey.
International journal of nursing studies 2011;48(12):1540-50.
2011: Arna H Arnardottir; Pieter A de Graeff; Flora M Haaijer-Ruskamp; Sabine M J M Straus; Peter G M Mol
Effect of safety issues with HIV drugs on the approval process of other drugs in the same class: an analysis of European Public Assessment Reports.
Drug safety : an international journal of medical toxicology and drug experience 2011;34(11):1101-14.
2011: Aileen B Dequito; Flora M Haaijer-Ruskamp; Peter G M Mol; Patricia M L A van den Bemt; Jasperien E van Doormaal; Rianne J Zaal; Jos G W Kosterink
Preventable and non-preventable adverse drug events in hospitalized patients: a prospective chart review in the Netherlands.
Drug safety : an international journal of medical toxicology and drug experience 2011;34(11):1089-100.
2011: Arna H Arnardottir; Pieter A de Graeff; Hans-Georg Eichler; Flora M Haaijer-Ruskamp; Sabine M J M Straus; Peter G M Mol
Additional safety risk to exceptionally approved drugs in Europe?
British journal of clinical pharmacology 2011;72(3):490-9.
2011: Grigory Sidorenkov; Flora M Haaijer-Ruskamp; Dick de Zeeuw; Henk Bilo; Petra Denig
Review: relation between quality-of-care indicators for diabetes and patient outcomes: a systematic literature review.
Medical care research and review : MCRR 2011;68(3):263-89.
2011: Ruth H E De Smedt; Flora M Haaijer-Ruskamp; Klaas H Groenier; Klaas van der Meer; Tiny Jaarsma
Perceived adverse drug events in heart failure: patients' perception and related factors.
The Journal of cardiovascular nursing 2011;26(3):250-60.
2011: Petra Denig; Flora M Haaijer-Ruskamp
Do we need individualised prescribing quality assessment? The case of diabetes treatment.
International journal of clinical pharmacy 2011;33(2):145-9.
2011: Liana Hakobyan; Dick De Zeeuw; Daniela Dobre; Flora M Haaijer-Ruskamp; Petra Denig
A review of methods used in assessing non-serious adverse drug events in observational studies among type 2 diabetes mellitus patients.
Health and quality of life outcomes 2011;9():83.
2011: Grigory Sidorenkov; Flora M Haaijer-Ruskamp; Dick De Zeeuw; Petra Denig
A longitudinal study examining adherence to guidelines in diabetes care according to different definitions of adequacy and timeliness.
PloS one 2011;6(9):e24278.
2011: Jaco Voorham; Flora M Haaijer-Ruskamp; Bruce H R Wolffenbuttel; Ronald P Stolk; Petra Denig
Medication adherence affects treatment modifications in patients with type 2 diabetes.
Clinical therapeutics 2011;33(1):121-34.
2010: Jasperien E van Doormaal; Mirjam K Rommers; Jos G W Kosterink; Irene M Teepe-Twiss; Flora M Haaijer-Ruskamp; Peter G M Mol
Comparison of methods for identifying patients at risk of medication-related harm.
Quality & safety in health care 2010;19(6):e26.
2010: Voorham Jaco; Flora M Haaijer-Ruskamp; Bruce Wolffenbuttel; R P Stolk; Petra Denig
Cardiometabolic treatment decisions in patients with type 2 diabetes: the role of repeated measurements and medication burden.
Quality & safety in health care 2010;19(5):411-5.
2010: Rianne J Zaal; Jasperien E van Doormaal; Albert W Lenderink; Peter G M Mol; Jos G W Kosterink; Toine C G Egberts; Flora M Haaijer-Ruskamp; Patricia M L A van den Bemt
Comparison of potential risk factors for medication errors with and without patient harm.
Pharmacoepidemiology and drug safety 2010;19(8):825-33.
2010: Jasperien E van Doormaal; Peter G M Mol; Rianne J Zaal; Patricia M L A van den Bemt; Jos G W Kosterink; Karin M Vermeulen; Flora M Haaijer-Ruskamp
Computerized physician order entry (CPOE) system: expectations and experiences of users.
Journal of evaluation in clinical practice 2010;16(4):738-43.
2010: Peter G M Mol; Sabine M J M Straus; Sigrid Piening; Jonie T N de Vries; Pieter A de Graeff; Flora M Haaijer-Ruskamp
A decade of safety-related regulatory action in the Netherlands: a retrospective analysis of direct healthcare professional communications from 1999 to 2009.
Drug safety : an international journal of medical toxicology and drug experience 2010;33(6):463-74.
2010: Liana Martirosyan; Voorham Jaco; Flora M Haaijer-Ruskamp; Jozé Braspenning; Bruce Wolffenbuttel; Petra Denig
A systematic literature review: prescribing indicators related to type 2 diabetes mellitus and cardiovascular risk management.
Pharmacoepidemiology and drug safety 2010;19(4):319-34.
2010: Ruth H E De Smedt; Tiny Jaarsma; Flora M Haaijer-Ruskamp; Petra Denig
The impact of perceived adverse effects on medication changes in heart failure patients.
Journal of cardiac failure 2010;16(2):135-41.e2.
2010: Liana Martirosyan; Onyebuchi A Arah; Flora M Haaijer-Ruskamp; Jozé Braspenning; Petra Denig
Methods to identify the target population: implications for prescribing quality indicators.
BMC health services research 2010;10():137.
2010: Voorham Jaco; Flora M Haaijer-Ruskamp; Klaas van der Meer; Dick de Zeeuw; Bruce Wolffenbuttel; Klaas Hoogenberg; Petra Denig
[Quality of the treatment of type 2 diabetes: results from the GIANTT project 2004-2007].
Nederlands tijdschrift voor geneeskunde 2010;154():A775.
2009: Jasperien E van Doormaal; Patricia Van den Bemt; Rianne J Zaal; Antoine C G Egberts; Bertil W Lenderink; Jos G W Kosterink; Flora M Haaijer-Ruskamp; Peter G M Mol
The influence that electronic prescribing has on medication errors and preventable adverse drug events: an interrupted time-series study.
Journal of the American Medical Informatics Association : JAMIA 2009;16(6):816-25.
2009: J E van Doormaal; Patricia Van den Bemt; P G M Mol; R J Zaal; Toine Egberts; Flora M Haaijer-Ruskamp; Jos G W Kosterink
Medication errors: the impact of prescribing and transcribing errors on preventable harm in hospitalised patients.
Quality & safety in health care 2009;18(1):22-7.
2009: Björn Wettermark; Brian Godman; Bengt Jacobsson; Flora M Haaijer-Ruskamp
Soft regulations in pharmaceutical policy making: an overview of current approaches and their consequences.
Applied health economics and health policy 2009;7(3):137-47.
2008: L Martirosyan; J Braspenning; Petra Denig; W J C de Grauw; Margriet Bouma; F Storms; Flora M Haaijer-Ruskamp
Prescribing quality indicators of type 2 diabetes mellitus ambulatory care.
Quality & safety in health care 2008;17(5):318-23.
2008: Ruth H E De Smedt; Tiny Jaarsma; Stan A J van den Broek; Flora M Haaijer-Ruskamp
Decompensation of chronic heart failure associated with pregabalin in a 73-year-old patient with postherpetic neuralgia: a case report.
British journal of clinical pharmacology 2008;66(2):327-8.
2008: Jasperien E van Doormaal; Peter G M Mol; Patricia Van den Bemt; Rianne J Zaal; Toine Egberts; Jos G W Kosterink; Flora M Haaijer-Ruskamp
Reliability of the assessment of preventable adverse drug events in daily clinical practice.
Pharmacoepidemiology and drug safety 2008;17(7):645-54.
2008: Larissa Grigoryan; Johannes G M Burgerhof; John E Degener; Reginald Deschepper; Cecilia Stålsby Lundborg; Dominique L Monnet; Elizabeth A Scicluna; Joan Birkin; Flora M Haaijer-Ruskamp
Determinants of self-medication with antibiotics in Europe: the impact of beliefs, country wealth and the healthcare system.
The Journal of antimicrobial chemotherapy 2008;61(5):1172-9.
2008: Daniela Dobre; Mike J L de Jongste; Flora M Haaijer-Ruskamp; Robbert Sanderman; Dirk J van Veldhuisen; Adelita Ranchor
The enigma of quality of life in patients with heart failure.
International journal of cardiology 2008;125(3):407-9.
2008: Voorham Jaco; Flora M Haaijer-Ruskamp; Ronald P Stolk; Bruce Wolffenbuttel; Petra Denig
Influence of elevated cardiometabolic risk factor levels on treatment changes in type 2 diabetes.
Diabetes care 2008;31(3):501-3.
2008: Voorham Jaco; Petra Denig; Bruce Wolffenbuttel; Flora M Haaijer-Ruskamp
Cross-sectional versus sequential quality indicators of risk factor management in patients with type 2 diabetes.
Medical care 2008;46(2):133-41.
2008: Reginald Deschepper; Larissa Grigoryan; Cecilia Stålsby Lundborg; Geert Hofstede; Joachim Cohen; Greta Van Der Kelen; Luc Deliens; Flora M Haaijer-Ruskamp
Are cultural dimensions relevant for explaining cross-national differences in antibiotic use in Europe?
BMC health services research 2008;8():123.
2007: Samuel Coenen; Matus Ferech; Flora M Haaijer-Ruskamp; Chris C Butler; Robert Vander Stichele; Theo J M Verheij; Dominique L Monnet; Paul S Little; Herman Goossens
European Surveillance of Antimicrobial Consumption (ESAC): quality indicators for outpatient antibiotic use in Europe.
Quality & safety in health care 2007;16(6):440-5.
2007: Larissa Grigoryan; Johannes G M Burgerhof; John E Degener; Reginald Deschepper; Cecilia Stålsby Lundborg; Dominique L Monnet; Elizabeth A Scicluna; Joan Birkin; Flora M Haaijer-Ruskamp
Attitudes, beliefs and knowledge concerning antibiotic use and self-medication: a comparative European study.
Pharmacoepidemiology and drug safety 2007;16(11):1234-43.
2007: Roy Stewart; Wim J M Niessen; Jan Broer; Tom A B Snijders; Flora M Haaijer-Ruskamp; Betty Meyboom-de Jong
General Practitioners reduced benzodiazepine prescriptions in an intervention study: a multilevel application.
Journal of clinical epidemiology 2007;60(10):1076-84.
2007: Daniela Dobre; Dirk J van Veldhuisen; Mike J L DeJongste; Eric van Sonderen; Olaf Klungel; Robbert Sanderman; Adelita Ranchor; Flora M Haaijer-Ruskamp
The contribution of observational studies to the knowledge of drug effectiveness in heart failure.
British journal of clinical pharmacology 2007;64(4):406-14.
2007: Daniela Dobre; Dirk J van Veldhuisen; Giacomo Mordenti; Marius Vintila; Flora M Haaijer-Ruskamp; Andrew J S Coats; Philip A Poole-Wilson; Marcus Flather
Tolerability and dose-related effects of nebivolol in elderly patients with heart failure: data from the Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure (SENIORS) trial.
American heart journal 2007;154(1):109-15.
2007: Mieke L Van Driel; Samuel Coenen; K Dirven; J Lobbestael; Isabelle Janssens; Paul Van Royen; Flora M Haaijer-Ruskamp; Marc De Meyere; Jan De Maeseneer; Thierry Christiaens
What is the role of quality circles in strategies to optimise antibiotic prescribing? A pragmatic cluster-randomised controlled trial in primary care.
Quality & safety in health care 2007;16(3):197-202.
2007: Daniela Dobre; Mike J L DeJongste; Carolien Lucas; Ger Cleuren; Dirk J van Veldhuisen; Adelita Ranchor; Flora M Haaijer-Ruskamp
Effectiveness of beta-blocker therapy in daily practice patients with advanced chronic heart failure; is there an effect-modification by age?
British journal of clinical pharmacology 2007;63(3):356-64.
2007: Jacoba P Greving; Petra Denig; Dick De Zeeuw; Flora M Haaijer-Ruskamp
Claims in advertisements for antihypertensive drugs in a Dutch medical journal.
Journal of hypertension 2007;25(3):713-22.
2007: Daniela Dobre; Dirk J van Veldhuisen; Mike J L DeJongste; Carolien Lucas; Ger Cleuren; Robbert Sanderman; Adelita Ranchor; Flora M Haaijer-Ruskamp
Prescription of beta-blockers in patients with advanced heart failure and preserved left ventricular ejection fraction. Clinical implications and survival.
European journal of heart failure 2007;9(3):280-6.
2007: Daniela Dobre; Cornelia H M van Jaarsveld; Mike J L DeJongste; Flora M Haaijer-Ruskamp; Adelita Ranchor
The effect of beta-blocker therapy on quality of life in heart failure patients: a systematic review and meta-analysis.
Pharmacoepidemiology and drug safety 2007;16(2):152-9.
2007: Daniela Dobre; Flora M Haaijer-Ruskamp; Adriaan A Voors; Dirk J van Veldhuisen
beta-Adrenoceptor antagonists in elderly patients with heart failure: a critical review of their efficacy and tolerability.
Drugs & aging 2007;24(12):1031-44.
2007: Jacoba P Greving; Petra Denig; Dick De Zeeuw; Henk J G Bilo; Flora M Haaijer-Ruskamp
Trends in hyperlipidemia and hypertension management in type 2 diabetes patients from 1998-2004: a longitudinal observational study.
Cardiovascular diabetology 2007;6():25.
2007: Larissa Grigoryan; Johannes G M Burgerhof; Flora M Haaijer-Ruskamp; John E Degener; Reginald Deschepper; Dominique L Monnet; Antonella Di Matteo; Elizabeth A Scicluna; Ana-Claudia Bara; Cecilia Stålsby Lundborg; Joan Birkin
Is self-medication with antibiotics in Europe driven by prescribed use?
The Journal of antimicrobial chemotherapy 2007;59(1):152-6.
2007: Heidrun B Sturm; Wiek H van Gilst; Nic J G M Veeger; Flora M Haaijer-Ruskamp
Prescribing for chronic heart failure in Europe: does the country make the difference? A European survey.
Pharmacoepidemiology and drug safety 2007;16(1):96-103.
2006: Willeke N Kasje; Petra Denig; Roy E Stewart; Pieter A de Graeff; Flora M Haaijer-Ruskamp
An educational programme for peer review groups to improve treatment of chronic heart failure and diabetes mellitus type 2 in general practice.
Journal of evaluation in clinical practice 2006;12(6):613-21.
2006: Jacoba P Greving; Petra Denig; Willem Jan van der Veen; Frank W Beltman; Miriam C J M Sturkenboom; Flora M Haaijer-Ruskamp
Determinants for the adoption of angiotensin II receptor blockers by general practitioners.
Social science & medicine (1982) 2006;63(11):2890-8.
2006: Daniela Dobre; Cornelia H M van Jaarsveld; Adelita Ranchor; Rosemarie Arnold; Mike J L de Jongste; Flora M Haaijer-Ruskamp
Evidence-based treatment and quality of life in heart failure.
Journal of evaluation in clinical practice 2006;12(3):334-40.
2006: Peter G M Mol; Petra Denig; Rijk O B Gans; Prashant V Nannanpanday; John E Degener; Marian Laseur; Flora M Haaijer-Ruskamp
Limited effect of patient and disease characteristics on compliance with hospital antimicrobial guidelines.
European journal of clinical pharmacology 2006;62(4):297-305.
2006: Anna Olczak; PAWEL GRZESIOWSKI; Waleria Hryniewicz; Flora M Haaijer-Ruskamp
[Self-medication with antibiotics in Poland].
Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 2006;20(116):151-4.
2006: Jacoba P Greving; Petra Denig; Dick De Zeeuw; Flora M Haaijer-Ruskamp
Physicians' attitudes towards treatment guidelines: differences between teaching and nonteaching hospitals.
European journal of clinical pharmacology 2006;62(2):129-33.
2006: Ausra Berzanskyte; Rolanda Valinteliene; Flora M Haaijer-Ruskamp; Romualdas Gurevicius; Larissa Grigoryan
Self-medication with antibiotics in Lithuania.
International journal of occupational medicine and environmental health 2006;19(4):246-53.
2006: Mark Muscat; Dominique L Monnet; Thomas Klemmensen; Larissa Grigoryan; Maria Hummelshøj Jensen; Morten Andersen; Flora M Haaijer-Ruskamp
Patterns of antibiotic use in the community in Denmark.
Scandinavian journal of infectious diseases 2006;38(8):597-603.
2006: Heidrun B Sturm; Flora M Haaijer-Ruskamp; Nic J G M Veeger; Corine P Baljé-Volkers; Karl Swedberg; Wiek H van Gilst
The relevance of comorbidities for heart failure treatment in primary care: A European survey.
European journal of heart failure 2006;8(1):31-7.
2005: Raul Raz; Hana Edelstein; Larissa Grigoryan; Flora M Haaijer-Ruskamp
Self-medication with antibiotics by a population in northern Israel.
The Israel Medical Association journal : IMAJ 2005;7(11):722-5.
2005: Peter G M Mol; Rijk O B Gans; P V Nannan Panday; John E Degener; Marian Laseur; Flora M Haaijer-Ruskamp
Reliability of assessment of adherence to an antimicrobial treatment guideline.
The Journal of hospital infection 2005;60(4):321-8.
2005: Jacoba P Greving; Petra Denig; Willem Jan van der Veen; Frank W Beltman; Miriam C J M Sturkenboom; Dick De Zeeuw; Flora M Haaijer-Ruskamp
Uptake of angiotensin II receptor blockers in the treatment of hypertension.
European journal of clinical pharmacology 2005;61(5-6):461-6.
2005: Willeke N Kasje; Petra Denig; Pieter A de Graeff; Flora M Haaijer-Ruskamp
Perceived barriers for treatment of chronic heart failure in general practice; are they affecting performance?
BMC family practice 2005;6(1):19.
2005: Willeke N Kasje; Petra Denig; Roy E Stewart; Pieter A de Graeff; Flora M Haaijer-Ruskamp
Physician, organisational and patient characteristics explaining the use of angiotensin converting enzyme inhibitors in heart failure treatment: a multilevel study.
European journal of clinical pharmacology 2005;61(2):145-51.
2005: Peter G M Mol; Jaap E Wieringa; Prashant V Nannanpanday; Rijk O B Gans; John E Degener; Marian Laseur; Flora M Haaijer-Ruskamp
Improving compliance with hospital antibiotic guidelines: a time-series intervention analysis.
The Journal of antimicrobial chemotherapy 2005;55(4):550-7.
2005: Tiny Jaarsma; Flora M Haaijer-Ruskamp; Heidrun B Sturm; Dirk J van Veldhuisen
Management of heart failure in The Netherlands.
European journal of heart failure 2005;7(3):371-5.
2005: W J M Niessen; R E Stewart; Jan Broer; Flora M Haaijer-Ruskamp
[Reduction in the consumption of benzodiazepines due to a letter to chronic users from their own general practitioner].
Nederlands tijdschrift voor geneeskunde 2005;149(7):356-61.
2005: Heidrun B Sturm; Wiek H van Gilst; Karl Swedberg; F D Richard Hobbs; Flora M Haaijer-Ruskamp
Heart failure guidelines and prescribing in primary care across Europe.
BMC health services research 2005;5():57.
2005: J L Hoven; Flora M Haaijer-Ruskamp; Robert Vander Stichele
Indicators of prescribing quality in drug utilisation research: report of a European meeting (DURQUIM, 13-15 May 2004).
European journal of clinical pharmacology 2005;60(11):831-4.
2004: Jacoba P Greving; Petra Denig; Willem Jan van der Veen; Frank W Beltman; Miriam C J M Sturkenboom; Dick De Zeeuw; Flora M Haaijer-Ruskamp
Does comorbidity explain trends in prescribing of newer antihypertensive agents?
Journal of hypertension 2004;22(11):2209-15.
2004: Willeke N Kasje; Petra Denig; Pieter A de Graeff; Flora M Haaijer-Ruskamp
Physicians' views on joint treatment guidelines for primary and secondary care.
International journal for quality in health care : journal of the International Society for Quality in Health Care / ISQua 2004;16(3):229-36.
2004: Lisa G Pont; Thys Van der Molen; Petra Denig; Ger Th van der Werf; Flora M Haaijer-Ruskamp
Relationship between guideline treatment and health-related quality of life in asthma.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2004;23(5):718-22.
2004: Peter G M Mol; Willem J M J Rutten; Rijk O B Gans; John E Degener; Flora M Haaijer-Ruskamp
Adherence barriers to antimicrobial treatment guidelines in teaching hospital, the Netherlands.
Emerging infectious diseases 2004;10(3):522-5.
2004: Emma Svensson; Flora M Haaijer-Ruskamp; Cecilia Stålsby Lundborg
Self-medication with antibiotics in a Swedish general population.
Scandinavian journal of infectious diseases 2004;36(6-7):450-2.
2004: Carel F Schaars; Petra Denig; Willeke N Kasje; Roy E Stewart; Bruce Wolffenbuttel; Flora M Haaijer-Ruskamp
Physician, organizational, and patient factors associated with suboptimal blood pressure management in type 2 diabetic patients in primary care.
Diabetes care 2004;27(1):123-8.
2004: Lisa G Pont; Petra Denig; Thys Van der Molen; Willem Jan van der Veen; Flora M Haaijer-Ruskamp
Validity of performance indicators for assessing prescribing quality: the case of asthma.
European journal of clinical pharmacology 2004;59(11):833-40.
2003: Lisa G Pont; Miriam C J M Sturkenboom; Wiek H van Gilst; Petra Denig; Flora M Haaijer-Ruskamp
Trends in prescribing for heart failure in Dutch primary care from 1996 to 2000.
Pharmacoepidemiology and drug safety 2003;12(4):327-34.
2003: Lisa G Pont; Wiek H van Gilst; Dirk J A Lok; Hans J A Kragten; Flora M Haaijer-Ruskamp
The relevance of heart failure severity for treatment with evidence-based pharmacotherapy in general practice.
European journal of heart failure 2003;5(2):187-93.
2002: Willeke N Kasje; Petra Denig; Flora M Haaijer-Ruskamp
Specialists' expectations regarding joint treatment guidelines for primary and secondary care.
International journal for quality in health care : journal of the International Society for Quality in Health Care / ISQua 2002;14(6):509-18.
2002: Willeke N Kasje; JW Timmer; Peter M Boendermaker; Flora M Haaijer-Ruskamp
Dutch GPs' perceptions: the influence of out-of-pocket costs on prescribing.
Social science & medicine (1982) 2002;55(9):1571-8.
2002: Reginald Deschepper; Robert Vander Stichele; Flora M Haaijer-Ruskamp
Cross-cultural differences in lay attitudes and utilisation of antibiotics in a Belgian and a Dutch city.
Patient education and counseling 2002;48(2):161-9.
2002: Petra Denig; Rolf Wahlström; Mark Chaput de Saintonge; Flora M Haaijer-Ruskamp
The value of clinical judgement analysis for improving the quality of doctors' prescribing decisions.
Medical education 2002;36(8):770-80.
2002: Ymkje Stienstra; Sandra Muller; Tjip S van der Werf; Ahmed Abdo-Rabbo; Flora M Haaijer-Ruskamp
Availability of drugs to admitted patients in Yemeni public hospitals.
European journal of clinical pharmacology 2002;58(1):79-80.
2002: Lisa G Pont; Ger Th van der Werf; Petra Denig; Flora M Haaijer-Ruskamp
Identifying general practice patients diagnosed with asthma and their exacerbation episodes from prescribing data.
European journal of clinical pharmacology 2002;57(11):819-25.
2001: CC Veninga; Petra Denig; Lisa G Pont; Flora M Haaijer-Ruskamp
Comparison of indicators assessing the quality of drug prescribing for asthma.
Health services research 2001;36(1 Pt 1):143-61.
2000: CC Veninga; Petra Denig; R Zwaagstra; Flora M Haaijer-Ruskamp
Improving drug treatment in general practice.
Journal of clinical epidemiology 2000;53(7):762-72.
2000: LJ Veehof; R Stewart; Flora M Haaijer-Ruskamp; B M Jong
The development of polypharmacy. A longitudinal study.
Family practice 2000;17(3):261-7.
2000: Per Lagerløv; CC Veninga; Maria Muskova; Eva Hummers-Pradier; C Stålsby Lundborg; M Andrew; Flora M Haaijer-Ruskamp
Asthma management in five European countries: doctors' knowledge, attitudes and prescribing behaviour. Drug Education Project (DEP) group.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2000;15(1):25-9.
2000: CC Veninga; Cecilia Stålsby Lundborg; Per Lagerløv; Eva Hummers-Pradier; Petra Denig; Flora M Haaijer-Ruskamp
Treatment of uncomplicated urinary tract infections: exploring differences in adherence to guidelines between three European countries. Drug Education Project Group.
The Annals of pharmacotherapy 2000;34(1):19-26.
1999: Eva Hummers-Pradier; Petra Denig; Thimothy Oke; Per Lagerløv; Rolf Wahlström; Flora M Haaijer-Ruskamp
GPs' treatment of uncomplicated urinary tract infections--a clinical judgement analysis in four European countries. DEP group. Drug Education Project.
Family practice 1999;16(6):605-7.
1999: CC Veninga; Per Lagerløv; Rolf Wahlström; Maria Muskova; Petra Denig; J Berkhof; M M Kochen; Flora M Haaijer-Ruskamp
Evaluating an educational intervention to improve the treatment of asthma in four European countries. Drug Education Project Group.
American journal of respiratory and critical care medicine 1999;160(4):1254-62.
1999: LJ Veehof; Roy E Stewart; Betty Meyboom-de Jong; Flora M Haaijer-Ruskamp
Adverse drug reactions and polypharmacy in the elderly in general practice.
European journal of clinical pharmacology 1999;55(7):533-6.
1999: LJ Veehof; R Stewart; Flora M Haaijer-Ruskamp; Betty Meyboom-de Jong
[Chronic polypharmacy in one-third of the elderly in family practice].
Nederlands tijdschrift voor geneeskunde 1999;143(2):93-7.
1998: D Bijl; Eric van Sonderen; Flora M Haaijer-Ruskamp
Prescription changes and drug costs at the interface between primary and specialist care.
European journal of clinical pharmacology 1998;54(4):333-6.
1996: E J Boerkamp; Flora M Haaijer-Ruskamp; J C Reuyl; A Versluis
The use of drug information sources by physicians: development of a data-generating methodology.
Social science & medicine (1982) 1996;42(3):379-88.
1995: Petra Denig; Flora M Haaijer-Ruskamp
Do physicians take cost into account when making prescribing decisions?
PharmacoEconomics 1995;8(4):282-90.
1995: A M van Trigt; Lolkje T W de Jong van den Berg; L M Voogt; J Willems; Th F J Tromp; Flora M Haaijer-Ruskamp
Setting the agenda: does the medical literature set the agenda for articles about medicines in the newspapers?
Social science & medicine (1982) 1995;41(6):893-9.
1995: A M Van Trigt; Flora M Haaijer-Ruskamp; Lolkje T W de Jong van den Berg
Reporting research in medical journals and newspapers.
BMJ (Clinical research ed.) 1995;311(6996):62.
1995: A M van Trigt; Lolkje T W de Jong van den Berg; M Pasman; Flora M Haaijer-Ruskamp; J Willems; Th F J Tromp
Information about drugs in family magazines.
Pharmacy world & science : PWS 1995;17(2):48-53.
1995: Flora M Haaijer-Ruskamp; Petra Denig
Impact of feedback and peer review on prescribing.
Occasional paper (Royal College of General Practitioners) 1995;(69):13-9.
1994: A M van Trigt; C M Waardenburg; Flora M Haaijer-Ruskamp; Lolkje T W de Jong van den Berg
Questions about drugs: how do pregnant women solve them?
Pharmacy world & science : PWS 1994;16(6):254-9.
1994: A M van Trigt; Lolkje T W de Jong van den Berg; Flora M Haaijer-Ruskamp; J Willems; Th F J Tromp
Journalists and their sources of ideas and information on medicines.
Social science & medicine (1982) 1994;38(4):637-43.
1993: Petra Denig; Flora M Haaijer-Ruskamp; H Wesseling; A Versluis
Drug expectations and drug choices of hospital physicians.
Journal of internal medicine 1993;234(2):155-63.
1993: Petra Denig; Flora M Haaijer-Ruskamp; H Wesseling; A Versluis
Towards understanding treatment preferences of hospital physicians.
Social science & medicine (1982) 1993;36(7):915-24.
1993: Petra Denig; Flora M Haaijer-Ruskamp; H Wesseling; A Versluis
[On which criteria are drug choices by hospital physicians based?].
Nederlands tijdschrift voor geneeskunde 1993;137(9):448-51.
1993: Flora M Haaijer-Ruskamp; E Hemminki
The social aspects of drug use.
WHO regional publications. European series 1993;45():97-124.
1993: Flora M Haaijer-Ruskamp; M N Dukes
The economic aspects of drug use.
WHO regional publications. European series 1993;45():125-45.
1993: Lolkje T W de Jong van den Berg; C M Waardenburg; Flora M Haaijer-Ruskamp; M N Dukes; H Wesseling
Drug use in pregnancy: a comparative appraisal of data collecting methods.
European journal of clinical pharmacology 1993;45(1):9-14.
1992: Lolkje T W de Jong van den Berg; Paul B van den Berg; Flora M Haaijer-Ruskamp; M N Dukes; H Wesseling
Handling of risk-bearing drugs during pregnancy. Do we choose less risky alternatives?
Pharmaceutisch weekblad. Scientific edition 1992;14(2):38-45.
1992: Petra Denig; Flora M Haaijer-Ruskamp
Therapeutic decision making of physicians.
Pharmaceutisch weekblad. Scientific edition 1992;14(1):9-15.
1991: Petra Denig; Flora M Haaijer-Ruskamp; A Versluis; H Wesseling
Prescribing pattern in a Dutch university hospital.
Journal of clinical pharmacy and therapeutics 1991;16(6):423-33.
1991: Lolkje T W de Jong van den Berg; Paul B van den Berg; Flora M Haaijer-Ruskamp; M N Dukes; H Wesseling
Investigating drug use in pregnancy. Methodological problems and perspectives.
Pharmaceutisch weekblad. Scientific edition 1991;13(1):32-8.
1991: Petra Denig; Flora M Haaijer-Ruskamp; H Wesseling; A Versluis
Impact of clinical trials on the adoption of new drugs within a university hospital.
European journal of clinical pharmacology 1991;41(4):325-8.
1991: Flora M Haaijer-Ruskamp; Lolkje T W de Jong van den Berg
Drug utilization studies and drug monitoring in The Netherlands.
Annali dell'Istituto superiore di sanità 1991;27(2):217-23.
1990: Flora M Haaijer-Ruskamp
Drug-utilization studies in The Netherlands.
Pharmaceutisch weekblad. Scientific edition 1990;12(3):91-6.
1990: Petra Denig; Flora M Haaijer-Ruskamp; D H Zijsling
Impact of a drug bulletin on the knowledge, perception of drug utility, and prescribing behavior of physicians.
DICP : the annals of pharmacotherapy 1990;24(1):87-93.
1989: Petra Denig; Flora M Haaijer-Ruskamp
[The decision process of the family physician in the choice of a drug].
Nederlands tijdschrift voor geneeskunde 1989;133(12):632-3.
1988: Petra Denig; Flora M Haaijer-Ruskamp; D H Zijsling
How physicians choose drugs.
Social science & medicine (1982) 1988;27(12):1381-6.